158 related articles for article (PubMed ID: 37970615)
1. Prevalence and risk factors of lymphatic dysfunction in cirrhosis patients with refractory ascites: An often unconsidered mechanism.
Arya R; Kumar R; Kumar T; Kumar S; Anand U; Priyadarshi RN; Maji T
World J Hepatol; 2023 Oct; 15(10):1140-1152. PubMed ID: 37970615
[TBL] [Abstract][Full Text] [Related]
2. Lymphatic dysfunction in advanced cirrhosis: Contextual perspective and clinical implications.
Kumar R; Anand U; Priyadarshi RN
World J Hepatol; 2021 Mar; 13(3):300-314. PubMed ID: 33815674
[TBL] [Abstract][Full Text] [Related]
3. Intestinal Lymphangiectasia Associated With Refractory Ascites in a Cirrhosis Patient.
Kumar R; Kumar T; Anand U; Priyadarshi RN
Cureus; 2021 Jan; 13(1):e12567. PubMed ID: 33564554
[TBL] [Abstract][Full Text] [Related]
4. Primary intestinal lymphangiectasia presenting as limb hemihyperplasia: a case report and literature review.
Khayat AA
BMC Gastroenterol; 2021 May; 21(1):225. PubMed ID: 34006223
[TBL] [Abstract][Full Text] [Related]
5. The deep inferior epigastric lymphatic cable flap connected to gastroepiploic lymph node flap for treatment of refractory chylous ascites: Report of two cases.
Ciudad P; Chen HC; Bustos SS; Manrique OJ; Bolletta A; Forte AJ; Huayllani MT; Agko M; Urbina JA; Date S; Kaya B
Microsurgery; 2021 May; 41(4):376-383. PubMed ID: 33864636
[TBL] [Abstract][Full Text] [Related]
6. Lymphedema tarda after liver transplantation: a case report and review of the literature.
Saab S; Nguyen S; Collins J; Kunder G; Busuttil RW
Exp Clin Transplant; 2006 Dec; 4(2):567-70. PubMed ID: 17238860
[TBL] [Abstract][Full Text] [Related]
7. Review article: the diagnostic approach and current management of chylous ascites.
Lizaola B; Bonder A; Trivedi HD; Tapper EB; Cardenas A
Aliment Pharmacol Ther; 2017 Nov; 46(9):816-824. PubMed ID: 28892178
[TBL] [Abstract][Full Text] [Related]
8. Lymphaticovenous anastomosis for treatment of refractory chylous ascites: A case report.
Tsuzaka S; Aiyama T; Kamachi H; Kakisaka T; Orimo T; Nagatsu A; Asahi Y; Maeda T; Kamiyama T; Taketomi A
Microsurgery; 2023 Sep; 43(6):606-610. PubMed ID: 37016794
[TBL] [Abstract][Full Text] [Related]
9. Recombinant VEGF-C (Cys156Ser) improves mesenteric lymphatic drainage and gut immune surveillance in experimental cirrhosis.
Juneja P; Ruhina Rahman SN; Jakhar D; Mourya AK; Tripathi DM; Kaur I; Tiwari V; Rohilla S; Gupta A; Rawal P; Baweja S; Rastogi A; Naidu VGM; Sarin SK; Banerjee S; Kaur S
JHEP Rep; 2023 Oct; 5(10):100816. PubMed ID: 37663117
[TBL] [Abstract][Full Text] [Related]
10. Assessing the risk of decompensation by ascites and spontaneous bacterial peritonitis in cirrhosis.
Dănulescu RM; Stanciu C; Trifan A
Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):320-6. PubMed ID: 25076694
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity and Specificity of the Stemmer Sign for Lymphedema: A Clinical Lymphoscintigraphic Study.
Goss JA; Greene AK
Plast Reconstr Surg Glob Open; 2019 Jun; 7(6):e2295. PubMed ID: 31624689
[TBL] [Abstract][Full Text] [Related]
12. Massive Chylous Ascites After Living Donor Nephrectomy Successfully Treated With Lymphatic Embolization.
Hiffa A; Schulte K; Saeed M; Gani I
J Investig Med High Impact Case Rep; 2022; 10():23247096211065631. PubMed ID: 35038891
[TBL] [Abstract][Full Text] [Related]
13. Chylous Ascites Secondary to Retroperitoneal Para-Aortic Lymphadenectomy: A Case Report.
Gil González Y; Laseca-Modrego M; Arencibia-Sánchez O; González García-Cano D; Martin Martinez AI
Cureus; 2022 Feb; 14(2):e22560. PubMed ID: 35345705
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of refractory ascites in cirrhosis.
Ennaifer R; Elleuch N; Romdhane H; Hefaiedh R; Cheikh M; Chaabouni S; Ben Nejma H; Bel Hadj N
Tunis Med; 2016 Jan; 94(1):12-5. PubMed ID: 27525599
[TBL] [Abstract][Full Text] [Related]
15. [Chylous ascites in cirrhotic and non-cirrhotic patients].
Casafont F; López-Arias MJ; Crespo J; Dueñas C; Sánchez-Antolín G; Rivero M; Pons Romero F
Gastroenterol Hepatol; 1997; 20(6):291-4. PubMed ID: 9296843
[TBL] [Abstract][Full Text] [Related]
16. Disorders of the intestinal mesenteric lymphatic system.
Fox U; Lucani G
Lymphology; 1993 Jun; 26(2):61-6. PubMed ID: 8355519
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of lectin pathway molecules and complement proteins in ascitic fluid and blood in patients with liver cirrhosis.
Glargaard S; Boysen T; Pilely K; Garred P; Ytting H
Scand J Gastroenterol; 2018 Jan; 53(1):64-69. PubMed ID: 28982257
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous chylous ascites of cirrhosis.
Rector WG
J Clin Gastroenterol; 1984 Aug; 6(4):369-72. PubMed ID: 6481122
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of prompt ascitic drain removal in cirrhosis with refractory ascites.
Wong YJ; Lum HM; Tan PT; Teo EK; Tan J; Kumar R; Thurairajah PH
Singapore Med J; 2021 Dec; 62(12):659-664. PubMed ID: 33866716
[TBL] [Abstract][Full Text] [Related]
20. Primary Intestinal Lymphangiectasia Manifested as Unusual Edemas and Effusions: A Case Report.
Wang X; Jin H; Wu W
Medicine (Baltimore); 2016 Mar; 95(10):e2849. PubMed ID: 26962779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
